PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 27 |
| PubMedID- 21448316 | Aim: to identify risk factors associated with metabolic syndrome in patients with type 2 diabetes mellitus according to three diagnostic criteria: world health organization (who), third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults - adult treatment panel iii (ncep-atp iii), and international diabetes federation (idf). |
| PubMedID- 24589612 | Objective: to study the correlation between adipocytokines levels and metabolic syndrome (ms) in patients with newly diagnosed type 2 diabetes mellitus (t2dm). |
| PubMedID- 21936688 | Metabolic syndrome (mets) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease. |
| PubMedID- 25737976 | Aims and objectives: to study the prevalence of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 23728331 | type 2 diabetes mellitus with metabolic syndrome developed at 30 weeks of age, and the body weights and plasma insulin levels of oletf rats at 60 weeks of age were lower than those of normal rats. |
| PubMedID- 22474593 | At present, little data exist about incidence and the risk factors associated with metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25054102 | Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 21089455 | [cardiac autonomous neuropathy and metabolic syndrome in patients with type 2 diabetes mellitus]. |
| PubMedID- 22922310 | type 2 diabetes mellitus has been associated with obesity, metabolic syndrome, cardiovascular diseases and cancer. |
| PubMedID- 23700465 | Obesity and comorbidities (metabolic syndrome, ms, leading to type 2 diabetes mellitus, dm2, cardiovascular disease, cvd, and non-alcoholic fatty liver disease, nafld) is due not only to environmental factors but also to maternal nutrition [1]. |
| PubMedID- 20142634 | This study was performed to establish whether only 2 sessions per week of combined aerobic and resistance exercise are enough to reduce glycated hemoglobin (hba(1c)) and to induce changes in skeletal muscle gene expression in type 2 diabetes mellitus (dm2) subjects with metabolic syndrome. |
| PubMedID- 24601861 | This study aims to assess the prevalence of the components of the metabolic syndrome in type 2 diabetes mellitus (t2dm) patients using the international diabetes federation (idf) worldwide definition. |
| PubMedID- 21498915 | type 2 diabetes mellitus (t2dm) associated with metabolic syndrome (mets) represents a high risk of cardiovascular disease. |
| PubMedID- 23173761 | Pcos is a hyperinsulinemic syndrome strongly associated with obesity and type 2 diabetes mellitus and has also been associated with high blood pressure, dyslipidemia and cardiovascular disease[2]. |
| PubMedID- 21409896 | The objective of the study was to observe the frequency of metabolic syndrome (mets) in patients with type 2 diabetes mellitus and study the relationship of insulin resistance with the metabolic syndrome and its different clinical parameters. |
| PubMedID- 23115071 | Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25782325 | [clinical evaluation of the influence of certain initial status parameters on the development of type 2 diabetes mellitus in patients with metabolic syndrome]. |
| PubMedID- 22809366 | In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11]. |
| PubMedID- 25657309 | Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. |
| PubMedID- 24171882 | Prevalence of metabolic syndrome in type 2 diabetes mellitus using ncep-atpiii, idf and who definition and its agreement in gwalior chambal region of central india. |
| PubMedID- 22389088 | The metabolic syndrome is often associated with type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, steatosis of the liver and other organs, as well as hypertension, type 2 diabetes mellitus, and atherosclerosis. |
| PubMedID- 26097823 | Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. |
| PubMedID- 25760026 | Insulin resistance is a common pathological state found in the metabolic syndromeassociated with obesity and type 2 diabetes mellitus, in which target tissues fail torespond properly to physiologic insulin levels (5,7). |
| PubMedID- 20197633 | Small, dense ldl and high-sensitivity c-reactive protein (hs-crp) in metabolic syndrome with type 2 diabetes mellitus. |
| PubMedID- 25561880 | Aim: the dietary contents have a very important role in the management of metabolic syndrome along with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22669833 | Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. |
| PubMedID- 26042596 | Nafld is the hepatic manifestation of metabolic syndrome and is associated with obesity, type 2 diabetes mellitus, dyslipidemia, high blood pressure, insulin resistance and cardiovascular disease [1–3]. |
Page: 1